scholarly article | Q13442814 |
P2093 | author name string | Yassine Sakar | |
Mihai Covasa | |||
Frank A Duca | |||
Timothy D Swartz | |||
P2860 | cites work | The composition of the maintenance diet alters flavor-preference conditioning by intragastric fat infusions in rats. | Q52199709 |
Intestinal lipid absorption is not affected in CD36 deficient mice | Q57232709 | ||
Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat | Q77649566 | ||
Dietary fat preferences are inversely correlated with peripheral gustatory fatty acid sensitivity | Q77939500 | ||
CD36 gene deletion reduces fat preference and intake but not post-oral fat conditioning in mice | Q81097674 | ||
Gastrointestinal flora and fat digestion in monogastrics | Q93748335 | ||
THE CHOLESTEROL-LOWERING EFFECT OF COMMERCIAL DIET FED TO GERMFREE AND CONVENTIONAL RATS | Q94302071 | ||
Taste Preference for Fatty Acids Is Mediated by GPR40 and GPR120 | Q22336992 | ||
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma | Q24300294 | ||
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 | ||
The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene | Q28138952 | ||
The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference | Q28476719 | ||
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 | Q28507400 | ||
Microbiota matures colonic epithelium through a coordinated induction of cell cycle-related proteins in gnotobiotic rat | Q28571223 | ||
Ghrelin induces adiposity in rodents | Q29619226 | ||
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells | Q30476839 | ||
Altered orosensory sensitivity to oils in CCK-1 receptor deficient rats | Q30477602 | ||
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. | Q33225025 | ||
Taste does not determine daily intake of dilute sugar solutions in mice | Q34305807 | ||
The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin | Q36477035 | ||
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 | Q36942662 | ||
CD36 and taste of fat. | Q37976161 | ||
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity | Q38319091 | ||
Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota | Q38333184 | ||
Health and economic burden of the projected obesity trends in the USA and the UK. | Q39713652 | ||
The gut microbiota modulates host energy and lipid metabolism in mice | Q39993460 | ||
Free fatty acids induce cholecystokinin secretion through GPR120. | Q40059721 | ||
Enhanced acceptance and metabolism of fats by rats fed a high-fat diet | Q41171780 | ||
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. | Q42931889 | ||
Fat absorption in germ-free and conventional rats artificially deprived of bile secretion | Q43255665 | ||
Plasma enteroglucagon, gastrin and peptide YY in conventional and germ-free rats refed with a fibre-free or fibre-supplemented diet. | Q43757682 | ||
Flavor preferences conditioned by sugars: Rats learn to prefer glucose over fructose | Q44569072 | ||
Decreased expression of CD36 in circumvallate taste buds of high-fat diet induced obese rats | Q45900084 | ||
A gut feeling for obesity: 7TM sensors on enteroendocrine cells | Q46223313 | ||
Sugar and fat conditioned flavor preferences in C57BL/6J and 129 mice: oral and postoral interactions | Q46450255 | ||
Impact of inulin and oligofructose on gastrointestinal peptides | Q46475862 | ||
Fatty acid responses in taste cells from obesity-prone and -resistant rats. | Q46774235 | ||
Corn oil and mineral oil stimulate sham feeding in rats | Q48891478 | ||
Absence of intestinal microbiota does not protect mice from diet-induced obesity. | Q51401205 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e39748 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota | |
P478 | volume | 7 |
Q35048916 | A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway |
Q37685359 | Alteration in Taste Perception in Cancer: Causes and Strategies of Treatment |
Q47709491 | Anxiety, Depression, and the Microbiome: A Role for Gut Peptides |
Q89673966 | Blunted Vagal Cocaine- and Amphetamine-Regulated Transcript Promotes Hyperphagia and Weight Gain |
Q89831575 | Dissociation of Adaptive Thermogenesis from Glucose Homeostasis in Microbiome-Deficient Mice |
Q61806988 | Eating for 3.8 × 10: Examining the Impact of Diet and Nutrition on the Microbiota-Gut-Brain Axis Through the Lens of Microbial Endocrinology |
Q35906455 | Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature. |
Q64940705 | Exploring Associations between Interindividual Differences in Taste Perception, Oral Microbiota Composition, and Reported Food Intake. |
Q58606898 | Exploring Interactions between the Gut Microbiota and Social Behavior through Nutrition |
Q61810258 | Gut Microbiota and Energy Homeostasis in Fish |
Q47832545 | Gut Microbiota and the Neuroendocrine System |
Q35243151 | Gut microbiota, nutrient sensing and energy balance |
Q46395958 | Gut-Brain Axis and Behavior |
Q26998106 | Gut/brain axis and the microbiota |
Q56514183 | Impact of high-fat feeding on basic helix-loop-helix transcription factors controlling enteroendocrine cell differentiation |
Q49487941 | Interindividual variability in gut microbiota and host response to dietary interventions |
Q64229562 | Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides |
Q28245530 | Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms |
Q99712059 | Lactobacillus rhamnosus Strains Relieve Loperamide-Induced Constipation via Different Pathways Independent of Short-Chain Fatty Acids |
Q30489570 | May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry |
Q35178233 | Neuropeptides and the microbiota-gut-brain axis |
Q89892428 | Neuropod Cells: Emerging Biology of the Gut-Brain Sensory Transduction |
Q26992197 | Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes |
Q36590565 | Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology |
Q37088255 | Obesity and Asthma: Microbiome-Metabolome Interactions |
Q38503042 | Oral and intestinal sweet and fat tasting: impact of receptor polymorphisms and dietary modulation for metabolic disease |
Q90583753 | Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control |
Q38741518 | Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. |
Q61448039 | Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial |
Q58608329 | Rationale of Probiotic Supplementation during Pregnancy and Neonatal Period |
Q90077272 | Regional Diversity of the Gastrointestinal Microbiome |
Q35834277 | Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota |
Q46945753 | Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats |
Q92458215 | Review: Chemosensing of nutrients and non-nutrients in the human and porcine gastrointestinal tract |
Q38766761 | Role of the vagus nerve in the development and treatment of diet-induced obesity |
Q57120648 | The Brain-Gut-Microbiome Axis |
Q60922886 | The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial |
Q39388328 | The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. |
Q30241392 | The Gut Microbiota: The Gateway to Improved Metabolism. |
Q90533544 | The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity |
Q61795702 | The Gut⁻Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director "Microbiome" |
Q64108732 | The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release |
Q26750612 | The Intestinal Microbiota in Metabolic Disease |
Q39290933 | The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A 'Ménage à Trois'? |
Q58098051 | The Microbiotic Highway to Health-New Perspective on Food Structure, Gut Microbiota, and Host Inflammation |
Q88650068 | The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective |
Q34776005 | The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120. |
Q34129414 | The effects of gut microbiota on CNS function in humans |
Q37571440 | The endocrinology of taste receptors |
Q35811086 | The gut microbiota modulates host amino acid and glutathione metabolism in mice |
Q64927277 | The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. |
Q48138111 | The microbiota-gut-brain axis in obesity |
Q47876982 | Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice. |
Q47137050 | Visceral Inflammation and Immune Activation Stress the Brain |
Search more.